Does discrimination cause harm to the body?

FHS
May 16, 2024
2:49 pm

Researchers investigate whether experiencing discrimination is associated with accelerated biological processes of aging.

Brexanolone by Sage Therapeutics for Post-Traumatic Stress Disorder (PTSD): Likelihood of Approval

Brexanolone is under clinical development by Sage Therapeutics and currently in Phase I for Post-Traumatic Stress Disorder (PTSD).

February 9, 2024

Judge keeps Amgen’s $10.7B tax liability suit alive

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

October 2, 2024

Large study confirms locked-in syndrome as the predominant outcome of non-fatal pediatric drowning

It is a far cry from the traditionally thought-of “vegetative state” in which the mind is absent while the body lives on. Indeed, it is

January 26, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.